DOX led to concomitant dose‐dependent cellular death and a decrease in the half‐maximal inhibitory concentration (IC50) in DDRGK1 knockout cells (Figure 7E), suggesting that DDRGK1 knockout enhances tumor sensitivity to DOX. This evidence concerns the gene DDRGK1 and neoplasm.